Literature DB >> 17823290

Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein composition.

Máire E Doyle1, Lori Boggs, Robert Attia, Lauren R Cooper, Daniel R Saban, Cuong Q Nguyen, Ammon B Peck.   

Abstract

Sjögren's syndrome (SjS) is a human autoimmune disease characterized by exocrine dysfunction resulting from chronic autoimmune attack primarily against the lacrimal and/or salivary glands. Although, we previously established a good correlation between SjS in humans and autoimmune exocrinopathy in NOD/LtJ mice an in-depth evaluation of lacrimal gland disease in the NOD/LtJ mouse has remained limited. This leaves a major gap in our understanding of the dacryoadenitis/keratoconjunctivitis sicca in this model. Here we characterize the development of the autoimmune dacryoadenitis in NOD/LtJ and NOD.B10-H2(b) mice in comparison with age- and sex-matched nonautoimmune CD1 mice. We observed a decline in tear production beginning at 8 weeks of age in both NOD/LtJ and NOD.B10-H2(b) mice, continuing throughout the 40 to 46 weeks studied. This correlated with a quantifiable increase in mixed T- and B-lymphocyte infiltrations in the extraorbital lacrimal glands. In addition, temporal differences in tear protein expression between NOD/LtJ and CD1 mice were identified using two-dimensional gel electrophoresis and tandem mass spectrometry. Thus, using this model we can identify potentially important pathophysiological mechanisms of the autoimmune attack and possible diagnostic markers for development of SjS-associated dacryoadenitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823290      PMCID: PMC1988872          DOI: 10.2353/ajpath.2007.070388

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

1.  Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy.

Authors:  S Cha; S C van Blockland; M A Versnel; F Homo-Delarche; H Nagashima; J Brayer; A B Peck; M G Humphreys-Beher
Journal:  Exp Clin Immunogenet       Date:  2001

Review 2.  Pathogenesis of Sjögren's syndrome.

Authors:  R I Fox; H I Kang
Journal:  Rheum Dis Clin North Am       Date:  1992-08       Impact factor: 2.670

Review 3.  Inefficient clearance of dying cells and autoreactivity.

Authors:  U S Gaipl; A Sheriff; S Franz; L E Munoz; R E Voll; J R Kalden; M Herrmann
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

4.  Tear fluid analysis in primary Sjögren's syndrome.

Authors:  H M Markusse; N J van Haeringen; A J Swaak; M Hogeweg; P T de Jong
Journal:  Clin Exp Rheumatol       Date:  1993 Mar-Apr       Impact factor: 4.473

Review 5.  Lactoperoxidase and hydrogen peroxide metabolism in the airway.

Authors:  Gregory E Conner; Matthias Salathe; Rosanna Forteza
Journal:  Am J Respir Crit Care Med       Date:  2002-12-15       Impact factor: 21.405

6.  Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?

Authors:  Ben Parkin; Jason B Chew; Valerie A White; Graciela Garcia-Briones; Mukesh Chhanabhai; Jack Rootman
Journal:  Ophthalmology       Date:  2005-09-15       Impact factor: 12.079

7.  A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.

Authors:  S Cha; J Brayer; J Gao; V Brown; S Killedar; U Yasunari; A B Peck
Journal:  Scand J Immunol       Date:  2004-12       Impact factor: 3.487

Review 8.  Sjögren's syndrome.

Authors:  Robert I Fox
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

9.  Lacrimal gland, cornea, and tear film in the NZB/NZW F1 hybrid mouse.

Authors:  J P Gilbard; L A Hanninen; R C Rothman; K R Kenyon
Journal:  Curr Eye Res       Date:  1987-10       Impact factor: 2.424

10.  TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma.

Authors:  Marcel Batten; Carrie Fletcher; Lai Guan Ng; Joanna Groom; Julie Wheway; Yacine Laâbi; Xiaoguan Xin; Pascal Schneider; Jurg Tschopp; Charles R Mackay; Fabienne Mackay
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

View more
  24 in total

1.  An autoimmune response to odorant binding protein 1a is associated with dry eye in the Aire-deficient mouse.

Authors:  Jason J DeVoss; Norbert P LeClair; Yafei Hou; Navdeep K Grewal; Kellsey P Johannes; Wen Lu; Ting Yang; Craig Meagher; Lawrence Fong; Erich C Strauss; Mark S Anderson
Journal:  J Immunol       Date:  2010-03-17       Impact factor: 5.422

Review 2.  The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.

Authors:  Amy Donate; Alexandria Voigt; Cuong Q Nguyen
Journal:  Expert Rev Clin Immunol       Date:  2014-02-10       Impact factor: 4.473

3.  Comprehensive Molecular Profiles of Functionally Effective MSC-Derived Extracellular Vesicles in Immunomodulation.

Authors:  Hyemee Kim; Min Joung Lee; Eun-Hye Bae; Jin Suk Ryu; Gagandeep Kaur; Hyeon Ji Kim; Jun Yeob Kim; Heather Barreda; Sung Youn Jung; Jong Min Choi; Taeko Shigemoto-Kuroda; Joo Youn Oh; Ryang Hwa Lee
Journal:  Mol Ther       Date:  2020-04-23       Impact factor: 11.454

Review 4.  Animal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome.

Authors:  Byung Ha Lee; Adrienne E Gauna; Kaleb M Pauley; Yun-Jong Park; Seunghee Cha
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

5.  Lacrimal Gland Inflammation Deregulates Extracellular Matrix Remodeling and Alters Molecular Signature of Epithelial Stem/Progenitor Cells.

Authors:  Takeshi Umazume; William M Thomas; Sabrina Campbell; Hema Aluri; Suharika Thotakura; Driss Zoukhri; Helen P Makarenkova
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

6.  Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice.

Authors:  Bruce Turpie; Takeru Yoshimura; Abha Gulati; Jose David Rios; Darlene A Dartt; Sharmila Masli
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

7.  Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjögren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.

Authors:  Cuong Q Nguyen; Ashok Sharma; Jin-Xiong She; Richard A McIndoe; Ammon B Peck
Journal:  Exp Eye Res       Date:  2008-10-18       Impact factor: 3.467

Review 8.  The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.

Authors:  Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Ophthalmology       Date:  2017-11       Impact factor: 12.079

9.  NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.

Authors:  Yaping Ju; Srikanth Reddy Janga; Wannita Klinngam; J Andrew MacKay; Dillon Hawley; Driss Zoukhri; Maria C Edman; Sarah F Hamm-Alvarez
Journal:  Exp Eye Res       Date:  2018-09-08       Impact factor: 3.467

10.  Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.

Authors:  Roy A Fava; Susan M Kennedy; Sheryl G Wood; Anne I Bolstad; Jadwiga Bienkowska; Adrian Papandile; John A Kelly; Clio P Mavragani; Margaret Gatumu; Kathrine Skarstein; Jeffrey L Browning
Journal:  Arthritis Res Ther       Date:  2011-11-01       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.